740 related articles for article (PubMed ID: 32760203)
1. The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases.
Yang X; Lu D; Zhuo J; Lin Z; Yang M; Xu X
Int J Biol Sci; 2020; 16(13):2357-2366. PubMed ID: 32760203
[TBL] [Abstract][Full Text] [Related]
2. The gut microbiota in retinal diseases.
Bringer MA; Gabrielle PH; Bron AM; Creuzot-Garcher C; Acar N
Exp Eye Res; 2022 Jan; 214():108867. PubMed ID: 34856206
[TBL] [Abstract][Full Text] [Related]
3. Interaction between the gut microbiome and mucosal immune system.
Shi N; Li N; Duan X; Niu H
Mil Med Res; 2017; 4():14. PubMed ID: 28465831
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota influence tumor development and Alter interactions with the human immune system.
Ge Y; Wang X; Guo Y; Yan J; Abuduwaili A; Aximujiang K; Yan J; Wu M
J Exp Clin Cancer Res; 2021 Jan; 40(1):42. PubMed ID: 33494784
[TBL] [Abstract][Full Text] [Related]
5. The gut-liver axis in immune remodeling of hepatic cirrhosis.
Guan H; Zhang X; Kuang M; Yu J
Front Immunol; 2022; 13():946628. PubMed ID: 37408838
[TBL] [Abstract][Full Text] [Related]
6. Gut-liver axis: gut microbiota in shaping hepatic innate immunity.
Wu X; Tian Z
Sci China Life Sci; 2017 Nov; 60(11):1191-1196. PubMed ID: 28840534
[TBL] [Abstract][Full Text] [Related]
7. The oral-gut-circulatory axis: from homeostasis to colon cancer.
Tortora SC; Agurto MG; Martello LA
Front Cell Infect Microbiol; 2023; 13():1289452. PubMed ID: 38029267
[TBL] [Abstract][Full Text] [Related]
8. Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis.
Liao L; Schneider KM; Galvez EJC; Frissen M; Marschall HU; Su H; Hatting M; Wahlström A; Haybaeck J; Puchas P; Mohs A; Peng J; Bergheim I; Nier A; Hennings J; Reißing J; Zimmermann HW; Longerich T; Strowig T; Liedtke C; Cubero FJ; Trautwein C
Gut; 2019 Aug; 68(8):1477-1492. PubMed ID: 30872395
[TBL] [Abstract][Full Text] [Related]
9. Diet-Regulating Microbiota and Host Immune System in Liver Disease.
Eom JA; Kwon GH; Kim NY; Park EJ; Won SM; Jeong JJ; Raja G; Gupta H; Asmelash Gebru Y; Sharma S; Choi YR; Kim HS; Yoon SJ; Hyun JY; Jeong MK; Park HJ; Min BH; Choi MR; Kim DJ; Suk KT
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34199182
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota changes and chronic hepatitis C virus infection.
Preveden T; Scarpellini E; Milić N; Luzza F; Abenavoli L
Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):813-819. PubMed ID: 28621554
[TBL] [Abstract][Full Text] [Related]
11. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
12. Dysbiosis and liver diseases (Review).
Nishikawa H; Fukunishi S; Asai A; Yokohama K; Ohama H; Nishiguchi S; Higuchi K
Int J Mol Med; 2021 Sep; 48(3):. PubMed ID: 34328191
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota and liver diseases.
Minemura M; Shimizu Y
World J Gastroenterol; 2015 Feb; 21(6):1691-702. PubMed ID: 25684933
[TBL] [Abstract][Full Text] [Related]
14. Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota.
Ohtani N; Hara E
Cancer Sci; 2021 Nov; 112(11):4433-4443. PubMed ID: 34533882
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota-Host Interactions in Inborn Errors of Immunity.
Castagnoli R; Pala F; Bosticardo M; Licari A; Delmonte OM; Villa A; Marseglia GL; Notarangelo LD
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572538
[TBL] [Abstract][Full Text] [Related]
16. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
Arab JP; Martin-Mateos RM; Shah VH
Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota and Alzheimer's Disease: Pathophysiology and Therapeutic Perspectives.
Li Y; Wang R; Li Q; Wang YJ; Guo J
J Alzheimers Dis; 2021; 83(3):963-976. PubMed ID: 34366348
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbiota in Intestinal and Liver Disease.
Jones RM; Neish AS
Annu Rev Pathol; 2021 Jan; 16():251-275. PubMed ID: 33234022
[TBL] [Abstract][Full Text] [Related]
19. Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer.
Hou X; Zheng Z; Wei J; Zhao L
Front Immunol; 2022; 13():1030745. PubMed ID: 36426359
[TBL] [Abstract][Full Text] [Related]
20. Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis.
Jiang JW; Chen XH; Ren Z; Zheng SS
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):19-27. PubMed ID: 30527903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
